131 results
Page 4 of 7
8-K
EX-99.1
bsoxp1tsmdme3y
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
s99ru5vd 601
24 Jun 20
Business combination disclosure
4:03pm
425
er4tw8
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.3
op0ft3ypl3
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
rwxjup 4trntrgj
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.2
773fa xyil
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
sghyb8af7tpsm
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
2nhcpyug5aueph86su
5 May 20
Invitae Reports More Than $64 Million in Revenue Driven by More Than 154,000 Samples Accessioned in the First Quarter of 2020
4:11pm
S-3ASR
5j0bxdinw7z
20 Apr 20
Automatic shelf registration
4:59pm
S-3ASR
ua2kwjqhqm
20 Apr 20
Automatic shelf registration
4:55pm
8-K
EX-99.1
bpofz
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
8-K
EX-99.2
l4nr7eeyzus5psj
6 Apr 20
Invitae Announces Pricing of Public Offering of Common Stock
5:00pm
424B5
kzy2yfwbbk
3 Apr 20
Prospectus supplement for primary offering
12:00am
424B5
gipifrhufondlp
1 Apr 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-99.1
1xmf1upx7m cpn7
1 Apr 20
Invitae Announces Proposed Public Offering of Common Stock
4:34pm
S-3ASR
ae2aigh u1zk9urpld
18 Mar 20
Automatic shelf registration
10:00pm